GRI Bio, Inc. financial data

Symbol
GRI on Nasdaq
Location
La Jolla, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 30 Jan 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 217% % -29%
Debt-to-equity 85% % 70%
Return On Equity -382% % -77%
Return On Assets -206% % -43%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,445,029 shares
Common Stock, Shares, Outstanding 497,693 shares 2552%
Entity Public Float $1,500,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 98,162 shares 1399%
Weighted Average Number of Shares Outstanding, Diluted 98,162 shares 1399%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $6,819,000 USD 81%
General and Administrative Expense $5,158,000 USD 15%
Operating Income (Loss) $11,977,000 USD -45%
Net Income (Loss) Attributable to Parent $11,956,000 USD -46%
Earnings Per Share, Basic -122 USD/shares 92%
Earnings Per Share, Diluted -122 USD/shares 92%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $8,229,000 USD 64%
Assets, Current $8,592,000 USD 53%
Property, Plant and Equipment, Net $3,000 USD -25%
Operating Lease, Right-of-Use Asset $71,000 USD -41%
Assets $8,666,000 USD 51%
Accounts Payable, Current $1,837,000 USD 105%
Employee-related Liabilities, Current $336,000 USD -0.3%
Accrued Liabilities, Current $750,000 USD 8.5%
Liabilities, Current $2,643,000 USD 62%
Operating Lease, Liability, Noncurrent $15,000 USD -79%
Liabilities $2,658,000 USD 56%
Retained Earnings (Accumulated Deficit) $51,696,000 USD -30%
Stockholders' Equity Attributable to Parent $6,008,000 USD 49%
Liabilities and Equity $8,666,000 USD 51%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,736,000 USD 21%
Net Cash Provided by (Used in) Financing Activities $11,000 USD -100%
Common Stock, Shares Authorized 250,000,000 shares 0%
Common Stock, Shares, Issued 497,693 shares 2552%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,747,000 USD -177%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8,229,000 USD 64%
Deferred Tax Assets, Valuation Allowance $19,951,000 USD 20%
Deferred Tax Assets, Gross $19,971,000 USD 19%
Operating Lease, Liability $71,000 USD -40%
Depreciation $4,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid $77,000 USD -44%
Property, Plant and Equipment, Gross $37,000 USD 8.8%
Operating Lease, Liability, Current $56,000 USD 17%
Lessee, Operating Lease, Liability, to be Paid, Year Two $15,000 USD -76%
Lessee, Operating Lease, Liability, to be Paid, Year One $62,000 USD 3.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6,000 USD -67%
Deferred Tax Assets, Operating Loss Carryforwards $16,784,000 USD 15%
Share-based Payment Arrangement, Expense $793,000 USD 436%